← Alle mensen

NI

Nikhil I Khushalani

9 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Nivolumab for Resected Stage III or IV Melanoma at 9 Years.

The New England journal of medicine · 22 januari 2026

Outcomes With Postrecurrence Systemic Therapy Following Adjuvant Checkpoint Inhibitor Treatment for Resected Melanoma...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024-11

Systemische therapie bij melanoom: ASCO 2023 richtlijn update

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 oktober 2023

Bempegaldesleukin plus nivolumab bij onbehandeld melanoom: PIVOT IO 001 fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 oktober 2023

Nivolumab-ipilimumab met of zonder SBRT bij gemetastaseerd MSI-H tumoren

Lancet (London, England) · 24 september 2022

Adjuvant nivolumab versus ipilimumab bij melanoom: CheckMate 238 vierjaars herbeoordeling

European journal of cancer (Oxford, England : 1990) · 2022-09

Adjuvant pembrolizumab versus IFNα2b of ipilimumab bij hoogrisico melanoom: S1404

Cancer discovery · 1 maart 2022

Systemische therapie bij melanoom: ASCO 2020 richtlijn

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 november 2020

Adjuvant nivolumab versus ipilimumab bij melanoom: CheckMate 238 vierjaars

The Lancet. Oncology · 2020-11